What is LOPJLB’s current signal on LXRX?

LOPJLB’s latest quantitative signal on Lexicon Pharmaceuticals, Inc. (LXRX) is SELL in a BEAR regime. Signals are updated daily.

What market regime is LXRX in?

Lexicon Pharmaceuticals, Inc. (LXRX) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Lexicon Pharmaceuticals, Inc. (LXRX) do?

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, …

Where is Lexicon Pharmaceuticals, Inc. based / listed?

Lexicon Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

Lexicon Pharmaceuticals, Inc. (LXRX) Stock · SELL · BEAR

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $1.0B
Avg volume: 3.1M
Beta: 1.03
P/E (TTM): -15.43

Short % float: 15.32%
Days to cover: 12.5
SI change: +0.3%

1W: -0.85%
1M: +1.31%
3M: +7.41%
YTD: +103.51%

vs SPY 1W: +0.34%
vs SPY 1M: -2.01%
vs SPY 3M: +5.02%
vs SPY YTD: +91.75%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Sector peers

Industry peers

Prediction markets

Company news